SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-12-007870
Filing Date
2012-08-08
Accepted
2012-08-07 18:01:22
Documents
5
Period of Report
2012-08-04
Items
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kvpharm_8k-080412.htm 8-K 41579
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 6647
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 21979
4 EXHIBIT 99.3 ex99-3.htm EX-99.3 15165
5 logo.jpg GRAPHIC 22058
  Complete submission text file 0001437749-12-007870.txt   117254
Mailing Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146
Business Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-09601 | Film No.: 121014563
SIC: 2834 Pharmaceutical Preparations